Mahindra & Mahindra (M&M) in a filing to the exchanges stated that it has reviewed its investment in SsangYong Motor Company (SYMC) worth 500 billion Korean Won (KRW) or USD 406 million. The company has also discussed the approach to capital allocation embracing COVID-19 impact.

Global rating agency, Moody’s Investor Service, placed private sector lender IndusInd Bank’s ratings under review for downgrade and cut its outlook on ICICI Bank, Axis Bank and IDBI Bank by a notch due to asset quality concerns.

Associated Alcohols & Breweries announced that the company has received permission from MP Drug & Food authorities for the production of alcohol-based hand sanitisers.

SRL informed that the credit rating agency has reaffirmed the company’s long-term issuer rating at CARE AA- with stable outlook and short-term issuer rating at CARE A1+. 

The shares of pharmaceutical company, Cipla Limited surged more than eight per cent on Friday after the company announced that it has successfully completed phase-3 of clinical end-point study for fluticasone propionate & salmeterol inhalation powder.

Cyient Limited announced that it has partnered with Hitachi Rail in order to accelerate the evolution of signalling technology as well as expand & enhance the latter’s project execution capacity.

Bank of Maharashtra announced that it will reduce its repo linked lending rate (RLLR) by 75 basis points from April 7, 2020.

New Fund Offers (NFOs) that are open for subscription.

Other gainers were Coal India, Sun Pharma, ONGC and RIL that closed higher by 12 per cent, 11 per cent, 7.7 per cent and 0.3 per cent, respectively.

Considering the weekly time frame, the stock of Astrazeneca Pharma India Limited bounced back from the edge of a rising trendline support that is formed by connecting the swing lows since December 2018, which coincides with long-term moving average, i.e. 100-week SMA level.